Indication:
• Gastric ulcer (GU)
• Duodenal ulcer (DU)
• Reflux esophagitis (RE) and (erosive esophagitis EE)
• Maintenance treatment of reflux esophagitis (erosive esophagitis) in patients with repeat recurrence and relapse of the condition
• Prevention of recurrence of gastric ulcer or duodenal ulcer during NSAIDs administration
• Adjunct to Helicobacter pylori eradication associated with: Gastric ulcer, duodenal ulcer, gastric MALT lymphoma, idiopathic thrombocytopenic purpura, the stomach after endoscopic resection of early stage cancer, or Helicobacter pylori gastritis